16.64澳幣0.08(0.48%)
2024/10/02更新
績效 / 1月4.59%
3月1.91%
1年16.36%
晨星評等-
- 1.現金0.00%
- 2.股票27.67%
- 3.債券0.00%
- 4.其他72.33%
- 1.美國72.33%
- 2.歐洲不包含歐元區18.81%
- 3.英國3.74%
- 4.日本2.84%
- 5.大洋洲0.97%
- 1.Eli Lilly and Co9.20%
- 2.UnitedHealth Group Inc8.23%
- 3.Novo Nordisk AS Class B7.93%
- 4.Merck & Co Inc6.25%
- 5.Roche Holding AG5.87%
- 6.Regeneron Pharmaceuticals Inc4.94%
- 7.Vertex Pharmaceuticals Inc4.78%
- 8.Gilead Sciences Inc4.14%
- 9.Elevance Health Inc4.10%
- 10.Intuitive Surgical Inc3.84%
- 1.現金0.00%
- 2.股票27.67%
- 3.債券0.00%
- 4.其他72.33%
- 1.美國72.33%
- 2.歐洲不包含歐元區18.81%
- 3.英國3.74%
- 4.日本2.84%
- 5.大洋洲0.97%
- 1.Eli Lilly and Co9.20%
- 2.UnitedHealth Group Inc8.23%
- 3.Novo Nordisk AS Class B7.93%
- 4.Merck & Co Inc6.25%
- 5.Roche Holding AG5.87%
- 6.Regeneron Pharmaceuticals Inc4.94%
- 7.Vertex Pharmaceuticals Inc4.78%
- 8.Gilead Sciences Inc4.14%
- 9.Elevance Health Inc4.10%
- 10.Intuitive Surgical Inc3.84%